Submit
OR
Scan bar / 2D code
Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) has not been approved or licensed by FDA, but has been authorized for emergency use by FDA, under an EUA to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals aged 6 months through 11 years of age. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564(b) (1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner. Please see EUA Fact Sheets at www.cvdvaccine-us.com.
Sorry! The lot number you entered (AB0000) does not exist.
Please enter another Lot # or contact Pfizer Customer Service at 800‑666‑7248, option 8 OR [email protected].
Monovalent mRNA COVID-19 vaccines are no longer authorized for emergency use in the United States. FDA and CDC guidance is to check inventory and dispose of monovalent mRNA vaccines according to state and local regulations.
Vaccine has not expired.
Based on the shelf life currently approved in United States of America (USA), the Expiry Date for Lot # (AB0000) is:
September 27, 2022
Vaccine is expired.
Based on the shelf life currently approved in United States of America (USA), the Expiry Date for Lot # (AB0000) is:
January 28, 2022
Service UnavailableThe system is facing some technical issues at the moment. Please try again in a few minutes.